Sung H, et al. Global Cancer Statistics 2020: GLOBOCAN estimates of incidence and mortality worldwide for 36 cancers in 185 countries. CA Cancer J Clin. 2021;71(3):209–49.

Article  PubMed  Google Scholar 

Blanco E, Shen H, Ferrari M. Principles of nanoparticle design for overcoming biological barriers to drug delivery. Nat Biotechnol. 2015;33(9):941–51.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Souri M, et al. Engineered strategies to enhance tumor penetration of drug-loaded nanoparticles. J Control Release. 2022;341:227–46.

Article  CAS  PubMed  Google Scholar 

Peng C, et al. Bibliometric and visualized analysis of ocular drug delivery from 2001 to 2020. J Control Release. 2022;345:625–45.

Article  CAS  PubMed  Google Scholar 

Shou X, et al. Knowledge domain and emerging trends of glucagon-like peptide 1 receptor agonists in cardiovascular research: a bibliometric analysis. Curr Probl Cardiol. 2023;48(8):101194.

Article  PubMed  Google Scholar 

Chen C. Science mapping: a systematic review of the literature. J Data Inf Sci. 2017;2:1–40.

CAS  Google Scholar 

Siegel RL, et al. Cancer statistics, 2022. CA Cancer J Clin. 2022;72(1):7–33.

Article  PubMed  Google Scholar 

Patra JK, et al. Nano based drug delivery systems: recent developments and future prospects. J Nanobiotechnol. 2018;16(1):71.

Article  Google Scholar 

Rosenblum D, et al. Progress and challenges towards targeted delivery of cancer therapeutics. Nat Commun. 2018;9(1):1410.

Article  PubMed  PubMed Central  Google Scholar 

Sindhwani S, et al. The entry of nanoparticles into solid tumours. Nat Mater. 2020;19(5):566–75.

Article  CAS  PubMed  Google Scholar 

Shi J, et al. Cancer nanomedicine: progress, challenges and opportunities. Nat Rev Cancer. 2017;17(1):20–37.

Article  CAS  PubMed  Google Scholar 

Wilhelm S, et al. Analysis of nanoparticle delivery to tumours. Nat Rev Mater. 2016;1(5):16014.

Article  CAS  Google Scholar 

Mura S, Nicolas J, Couvreur P. Stimuli-responsive nanocarriers for drug delivery. Nat Mater. 2013;12(11):991–1003.

Article  CAS  PubMed  Google Scholar 

Bertrand N, et al. Cancer nanotechnology: the impact of passive and active targeting in the era of modern cancer biology. Adv Drug Deliv Rev. 2014;66:2–25.

Article  CAS  PubMed  Google Scholar 

Lahooti B, et al. Targeting endothelial permeability in the EPR effect. J Control Release. 2023;361:212–35.

Article  CAS  PubMed  Google Scholar 

Hamadani CM, et al. Development of ionic liquid-coated PLGA nanoparticles for applications in intravenous drug delivery. Nat Protoc. 2023;18(8):2509–57.

Article  CAS  PubMed  Google Scholar 

Liang A, et al. Effects of individual amino acids on the blood circulation of biosynthetic protein nanocages: toward guidance on surface engineering. Adv Healthc Mater. 2023;12(26):e2300502.

Article  PubMed  Google Scholar 

Li J, et al. Research progress on multi-target regulation strategies of tumor microenvironment based on nano-drug delivery system. Acta Pharm Sin. 2023;58(03):536–49.

Google Scholar 

Wang M, et al. Tumor microenvironment-mediated NIR-I-to-NIR-II transformation of Au self-assembly for theranostics. Acta Biomater. 2023;168:606–16.

Article  PubMed  Google Scholar 

Song S, et al. Multiple therapeutic mechanisms of pyrrolic N-rich g-C (3)N (4) nanosheets with enzyme-like function in the tumor microenvironment. J Colloid Interface Sci. 2023;650(Pt B):1125–37.

Article  CAS  PubMed  Google Scholar 

Yang L, et al. Engineered Toll-like receptor nanoagonist binding to extracellular matrix elicits safe and robust antitumor immunity. ACS Nano. 2023;17(6):5340–53.

Article  CAS  PubMed  Google Scholar 

Irvine DJ, Dane EL. Enhancing cancer immunotherapy with nanomedicine. Nat Rev Immunol. 2020;20(5):321–34.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li H, et al. A near-infrared-II fluorescent nanocatalyst for enhanced CAR T cell therapy against solid tumor by immune reprogramming. ACS Nano. 2023;17(12):11749–63.

Article  CAS  PubMed  Google Scholar 

Kar A, et al. A localized hydrogel-mediated chemotherapy causes immunogenic cell death via activation of ceramide-mediated unfolded protein response. Sci Adv. 2023;9(26):eadf2746.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Yin B, et al. Smart design of nanostructures for boosting tumor immunogenicity in cancer immunotherapy. Pharmaceutics. 2023;15(5):1427.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li T, et al. pH-activatable copper-biomineralized proenzyme for synergistic chemodynamic/chemo-immunotherapy against aggressive cancers. Adv Mater. 2022;35(14):e2210201.

Article  Google Scholar 

Miron-Barroso S, Domenech EB, Trigueros S. Nanotechnology-based strategies to overcome current barriers in gene delivery. Int J Mol Sci. 2021;22(16):8537.

Article  PubMed  PubMed Central  Google Scholar 

Choi EH, et al. Genome editing in the treatment of ocular diseases. Exp Mol Med. 2023;55(8):1678–90.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Xu X, et al. Nanotechnology-based delivery of CRISPR/Cas9 for cancer treatment. Adv Drug Deliv Rev. 2021;176:113891.

Article  CAS  PubMed  Google Scholar 

Chen Y, Ping Y. Development of CRISPR/Cas delivery systems for in vivo precision genome editing. Acc Chem Res. 2023;56(16):2185–96.

Article  CAS  PubMed  Google Scholar 

Kim J, et al. Self-assembled mRNA vaccines. Adv Drug Deliv Rev. 2021;170:83–112.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Li X, et al. Clinical development and potential of photothermal and photodynamic therapies for cancer. Nat Rev Clin Oncol. 2020;17(11):657–74.

Article  PubMed  Google Scholar 

Fu Y, et al. Oxygen-generating organic/inorganic self-assembled nanocolloids for tumor-activated dual-model imaging-guided photodynamic therapy. ACS Appl Mater Interfaces. 2023;15(30):36013–24.

Article  CAS  PubMed  Google Scholar 

Liu B, et al. Highly efficient far-red/NIR-absorbing neutral Ir (III) complex micelles for potent photodynamic/photothermal therapy. Adv Mater. 2021;33(32):e2100795.

Article  PubMed  Google Scholar 

Zhai Y, et al. Self-activated arsenic manganite nanohybrids for visible and synergistic thermo/immuno-arsenotherapy. J Control Release. 2022;350:761–76.

Article  CAS  PubMed  Google Scholar 

Fan D, et al. Nanomedicine in cancer therapy. Signal Transduct Target Ther. 2023;8(1):293.

Article  PubMed  PubMed Central  Google Scholar 

Shan X, et al. Current approaches of nanomedicines in the market and various stage of clinical translation. Acta Pharm Sin B. 2022;12(7):3028–48.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Hou X, et al. Lipid nanoparticles for mRNA delivery. Nat Rev Mater. 2021;6(12):1078–94.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Tracey SR, et al. Development of next generation nanomedicine-based approaches for the treatment of cancer: we’ve barely scratched the surface. Biochem Soc Trans. 2021;49(5):2253–69.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Mitchell MJ, et al. Engineering precision nanoparticles for drug delivery. Nat Rev Drug Discov. 2021;20(2):101–24.

Article  CAS  PubMed  Google Scholar